Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetics of capecitabine in advanced breast cancer patients.
Largillier R, Etienne-Grimaldi MC, Formento JL, Ciccolini J, Nebbia JF, Ginot A, Francoual M, Renée N, Ferrero JM, Foa C, Namer M, Lacarelle B, Milano G. Largillier R, et al. Among authors: ferrero jm. Clin Cancer Res. 2006 Sep 15;12(18):5496-502. doi: 10.1158/1078-0432.CCR-06-0320. Clin Cancer Res. 2006. PMID: 17000685
[Antidepressants in oncology: issues and clinical perspectives].
Barrière J, Cherikh F, Pringuey D, Milano G, Ferrero JM. Barrière J, et al. Among authors: ferrero jm. Bull Cancer. 2008 Nov;95(11):1103-11. doi: 10.1684/bdc.2008.0736. Bull Cancer. 2008. PMID: 19036683 Free article. French.
Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors.
Bondiau PY, Bahadoran P, Lallement M, Birtwisle-Peyrottes I, Chapellier C, Chamorey E, Courdi A, Quielle-Roussel C, Thariat J, Ferrero JM. Bondiau PY, et al. Among authors: ferrero jm. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1041-7. doi: 10.1016/j.ijrobp.2008.12.037. Epub 2009 Apr 20. Int J Radiat Oncol Biol Phys. 2009. PMID: 19386428 Clinical Trial.
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.
Pierga JY, Petit T, Delozier T, Ferrero JM, Campone M, Gligorov J, Lerebours F, Roché H, Bachelot T, Charafe-Jauffret E, Pavlyuk M, Kraemer S, Bidard FC, Viens P. Pierga JY, et al. Among authors: ferrero jm. Lancet Oncol. 2012 Apr;13(4):375-84. doi: 10.1016/S1470-2045(12)70049-9. Epub 2012 Feb 28. Lancet Oncol. 2012. PMID: 22377126 Clinical Trial.
282 results